Cargando…
Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis
SIMPLE SUMMARY: This review will summarise the landmark clinical trials leading to the first tissue-agnostic approval of immune checkpoint inhibitors in specific molecular profiles of recurrent endometrial cancer (EC). As this treatment is a novel therapy and yet to be integrated into routine clinic...
Autores principales: | Johnson, Racheal Louise, Ganesan, Subhasheenee, Thangavelu, Amudha, Theophilou, Georgios, de Jong, Diederick, Hutson, Richard, Nugent, David, Broadhead, Timothy, Laios, Alexandros, Cummings, Michele, Orsi, Nicolas Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527181/ https://www.ncbi.nlm.nih.gov/pubmed/37760602 http://dx.doi.org/10.3390/cancers15184632 |
Ejemplares similares
-
Development of a Novel Intra-Operative Score to Record Diseases’ Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial Intelligence
por: Laios, Alexandros, et al.
Publicado: (2023) -
Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian Cancer
por: Laios, Alexandros, et al.
Publicado: (2022) -
The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction
por: Johnson, Racheal Louise, et al.
Publicado: (2021) -
Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramifications
por: de Jong, Diederick, et al.
Publicado: (2023) -
Feature Selection is Critical for 2-Year Prognosis in Advanced Stage High Grade Serous Ovarian Cancer by Using Machine Learning
por: Laios, Alexandros, et al.
Publicado: (2021)